TrialTrials2020
A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP).
Fiona J Gifford et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
TrialTrials2020
Fiona J Gifford et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.